Youssef Ramadan

Dr. Youssef Ramadan


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MAMuhammad Faizan Ali
Muhammad Faizan Ali
HAHusnain Ahmad
Husnain Ahmad
MQMaria Qadri
Maria Qadri
Sherif EltawansySherif Eltawansy
Sherif Eltawansy
MAMuhammad Usman Arshad
Muhammad Usman Arshad
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida

17 August 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MAMuhammad Faizan Ali
Muhammad Faizan Ali
HAHusnain Ahmad
Husnain Ahmad
AMArun Maloth
Arun Maloth
HKHarsh Kumar
Harsh Kumar
YRYoussef Ramadan
Youssef Ramadan
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida

23 September 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MSMifrah Rahat Khan Sherwani
Mifrah Rahat Khan Sherwani
FKFilza Rahat Khan
Filza Rahat Khan
YRYoussef Ramadan
Youssef Ramadan
DBDua Bashir
Dua Bashir
ABAisha Bashir
Aisha Bashir
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida

24 September 2026 in International Journal of Cancer Care and Delivery
Verified
Journal Article
Open access
PDF file
FRFatma A. Rikabe
Fatma A. Rikabe
AMAbdelrhman H. Mohamed
Abdelrhman H. Mohamed
AEAlaa El-Deeb
Alaa El-Deeb
YRYoussef Ramadan
Youssef Ramadan
NFNoor Fatima
Noor Fatima
AGAbdelrahman Gouda
Abdelrahman Gouda
From the 8th International Cancer Congress

15 September 2026 in ASIDE Cardiovascular
Verified
Journal Article
Open access
PDF file
MAMohamed Alatfawy
Mohamed Alatfawy
YRYoussef Ramadan
Youssef Ramadan
AMAbdelrhman H. Mohamed
Abdelrhman H. Mohamed
MSMaryam Saghir
Maryam Saghir
AIAlyaa Ahmed Ibrahim
Alyaa Ahmed Ibrahim
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida
Background: Ischemic heart disease (IHD) is a leading cause of death in the United States, and death certificates may contain medical or surgical care-related codes among decedents with IHD. However, these codes do not establish procedural exposure, postoperative status, timing, or causality. This study assesses 25-year trends in mortality involving IHD and Y83–Y84 codes. Methods: Nationwide multiple-cause-of-death (MCOD) death-certificate records were obtained from the CDC WONDER database for U.S. adults aged ≥25 years from 1999–2023. Death records containing IHD (ICD-10 codes I20–I25) and medical/surgical care-related codes (Y83–Y84) were identified. We calculated age-adjusted mortality rates (AAMRs) per 100,000 people in the general U.S. population. We used joinpoint regression to estimate annual percentage changes (APCs) and average annual percentage changes (AAPCs). Results: From 1999–2023, a total of 144,644 deaths were reported. The AAMR significantly decreased from 4.19 in 1999 to 1.13 in 2023 (AAPC: -5.51; p = 0.000021). The overall AAMR was 3.78 (AAPC: −5.26) among males and 1.71 (AAPC: −6.12) among females. By race, AAMRs declined substantially among all groups from 1999 to 2023, with the highest 1999 AAMR observed among NH White individuals (4.35). Regionally, the Midwest had the highest overall AAMR (2.75). Adults aged ≥65 years had the highest overall CMR (10.34). From 1999 to 2020, the population-level AAMR was 3.21 in nonmetropolitan areas and 2.45 in metropolitan areas. Conclusion: Mortality involving IHD and medical/surgical procedure-related codes declined in recent years, particularly during 2021–2023. Higher population-level mortality rates were observed among males and in the Midwest region.

23 October 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
YRYoussef Ramadan
Youssef Ramadan
MEMostafa Mohamed Abdelmoneam Elsawy
Mostafa Mohamed Abdelmoneam Elsawy
MHMohamed Fawzi Hemida
Mohamed Fawzi Hemida